MIA COLLUCCI: Open Payments
NPI 1841929411 · RED BANK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 66 payments from 10 companies in 2025. Trend: 2023 $2,429 · 2024 $3,242 · 2025 $1,029
Food & beverage: $1,029
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $253 |
| Amgen Inc. | 10 | $250 |
| ABBVIE INC. | 17 | $184 |
| Novartis Pharmaceuticals Corporation | 9 | $171 |
| PFIZER INC. | 5 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Organon LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: Otezla, COSENTYX, TREMFYA, RINVOQ, SIMPONI ARIA, XELJANZ, SKYRIZI, SAPHNELO.
Industry payments across NJ — which companies pay providers there.
